May 14, 2020
Technological Advances in the Anti-Viral Drug Therapy Market to Aid Treatment of COVID-19 Patients, Reports TBRC
May 01, 2020
Gladstone Scientists Identify a New Potential Reservoir of Latent HIV
Apr 08, 2020
Viriom Initiates Phase 2 Clinical Study of Elsulfavirine for Treatment of COVID-19
Mar 22, 2020
Gladstone Institutes Responds to COVID-19 Pandemic
Feb 17, 2020
Viriom to present results of Phase I study of the long acting injectable formulation of novel NNRTi for treatment of HIV-1 infection at CROI 2020
Jan 27, 2020
AIDS Foundation Houston increases access to PrEP with MISTR partnership
Jan 13, 2020
HIV+ Briton challenges rules to qualify as commercial pilot
Dec 03, 2019
Viriom Launches Reproductive Toxicity Studies for Elpida® (Elsulfavirine) Once Weekly Oral Formulation
Nov 25, 2019
New Survey of Young Adults Uncovers Low Levels of Accurate Knowledge About HIV Transmission Coupled with High-Risk Sexual Behaviors
Nov 06, 2019
Abbott Announces Discovery of New Strain of HIV, Keeping Global Health Community a Step Ahead of the Virus
Nov 05, 2019
FDA authorizes marketing of first next-generation sequencing test for detecting HIV-1 drug resistance mutations
Oct 03, 2019
GT Biopharma Announces HIV TriKE(TM) Data Demonstrating NK Cell Killing of Patient HIV Infected Cells
Sep 26, 2019
GT Biopharma Announces HIV Trike(TM) Data to be Published
Sep 25, 2019
+Life Launches to #EndHIVstigma; POSE creator Steven Canals first exclusive interview
Sep 17, 2019
The global immunoassay market is expected to reach US$ 37,987.8 Mn in 2027 from US$ 21,800.0 in 2018
Sep 04, 2019
Research Foundation to Cure Aids (RFTCA) Accelerates a Global Cure for Aids With License of Chromocell's Proprietary Cell Engineering Technology
Sep 03, 2019
US HIV Market and Competitive Landscape 2019-2024: Treatments, Pipeline, Epidemiology, Marketed Drugs, Size, Sales, Competitive Landscape
Aug 28, 2019
HIV-Positive New Yorkers Are Living Longer but Still Dying of Underlying Infection, Not Just from Old Age
Jul 18, 2019
/R E P E A T -- Government of Canada Launches Action Plan on Sexually Transmitted and Blood-Borne Infections/
Jul 11, 2019
The HIV test kits market at a CAGR of more than 7% during the forecast period